Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.
Lai C, Ranpura V, Wu C, Olnes MJ, Parikh AR, Shenoy A, Thompson J, Weinstein B, Scheinberg P, Barrett AJ, Desmond R, Young NS, Hourigan CS.
Lai C, et al. Among authors: shenoy a.
Blood Adv. 2019 Apr 9;3(7):980-983. doi: 10.1182/bloodadvances.2018030411.
Blood Adv. 2019.
PMID: 30936058
Free PMC article.
No abstract available.